Source: GWASCAT ×
Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs13405728
rs13405728
LHCGR ; STON1-GTF2A1L
A 0.900 GeneticVariation GWASCAT Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome. 22885925

2012
dbSNP: rs2479106
rs2479106
DENND1A
G 0.900 GeneticVariation GWASCAT Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome. 22885925

2012
dbSNP: rs13405728
rs13405728
LHCGR ; STON1-GTF2A1L
A 0.900 GeneticVariation GWASCAT We identified strong evidence of associations between PCOS and three loci: 2p16.3 (rs13405728; combined P-value by meta-analysis P(meta) = 7.55 × 10⁻²¹, odds ratio (OR) 0.71); 2p21 (rs13429458, P(meta) = 1.73 × 10⁻²³, OR 0.67); and 9q33.3 (rs2479106, P(meta) = 8.12 × 10⁻¹⁹, OR 1.34). 21151128

2011
dbSNP: rs2479106
rs2479106
DENND1A
G 0.900 GeneticVariation GWASCAT We identified strong evidence of associations between PCOS and three loci: 2p16.3 (rs13405728; combined P-value by meta-analysis P(meta) = 7.55 × 10⁻²¹, odds ratio (OR) 0.71); 2p21 (rs13429458, P(meta) = 1.73 × 10⁻²³, OR 0.67); and 9q33.3 (rs2479106, P(meta) = 8.12 × 10⁻¹⁹, OR 1.34). 21151128

2011
dbSNP: rs13429458
rs13429458
THADA
A 0.890 GeneticVariation GWASCAT Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome. 22885925

2012
dbSNP: rs13429458
rs13429458
THADA
A 0.890 GeneticVariation GWASCAT We identified strong evidence of associations between PCOS and three loci: 2p16.3 (rs13405728; combined P-value by meta-analysis P(meta) = 7.55 × 10⁻²¹, odds ratio (OR) 0.71); 2p21 (rs13429458, P(meta) = 1.73 × 10⁻²³, OR 0.67); and 9q33.3 (rs2479106, P(meta) = 8.12 × 10⁻¹⁹, OR 1.34). 21151128

2011
dbSNP: rs2059807
rs2059807
INSR
G 0.830 GeneticVariation GWASCAT Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome. 22885925

2012
dbSNP: rs10818854
rs10818854
DENND1A
A 0.830 GeneticVariation GWASCAT Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3. 21151128

2011
dbSNP: rs12478601
rs12478601
THADA
C 0.820 GeneticVariation GWASCAT Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3. 21151128

2011
dbSNP: rs2268361
rs2268361
FSHR
C 0.810 GeneticVariation GWASCAT Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome. 22885925

2012
dbSNP: rs2272046
rs2272046
HMGA2
A 0.810 GeneticVariation GWASCAT Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome. 22885925

2012
dbSNP: rs3802457
rs3802457
AOPEP
G 0.810 GeneticVariation GWASCAT Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome. 22885925

2012
dbSNP: rs705702
rs705702
RAB5B ; SUOX
G 0.810 GeneticVariation GWASCAT Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome. 22885925

2012
dbSNP: rs1894116
rs1894116
YAP1
G 0.800 GeneticVariation GWASCAT Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome. 22885925

2012
dbSNP: rs4784165
rs4784165
LOC107984901
G 0.800 GeneticVariation GWASCAT Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome. 22885925

2012
dbSNP: rs6022786
rs6022786 		A 0.800 GeneticVariation GWASCAT Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome. 22885925

2012
dbSNP: rs11031006
rs11031006
LOC105376607
A 0.710 GeneticVariation GWASCAT The same chr 11p14.1 SNP, rs11031006, in the region of the follicle-stimulating hormone B polypeptide (FSHB) gene strongly associates with PCOS diagnosis and luteinizing hormone levels. 26284813

2015
dbSNP: rs11031006
rs11031006
LOC105376607
A 0.710 GeneticVariation GWASCAT Causal mechanisms and balancing selection inferred from genetic associations with polycystic ovary syndrome. 26416764

2015
dbSNP: rs1351592
rs1351592
ERBB4
G 0.710 GeneticVariation GWASCAT Causal mechanisms and balancing selection inferred from genetic associations with polycystic ovary syndrome. 26416764

2015
dbSNP: rs1159315
rs1159315
GABRB1
G 0.700 GeneticVariation GWASCAT High Genetic Risk Scores of ASIC2, MACROD2, CHRM3, and C2orf83 Genetic Variants Associated with Polycystic Ovary Syndrome Impair Insulin Sensitivity and Interact with Energy Intake in Korean Women. 30343302

2019
dbSNP: rs2060941
rs2060941
IKZF3
A 0.700 GeneticVariation GWASCAT High Genetic Risk Scores of ASIC2, MACROD2, CHRM3, and C2orf83 Genetic Variants Associated with Polycystic Ovary Syndrome Impair Insulin Sensitivity and Interact with Energy Intake in Korean Women. 30343302

2019
dbSNP: rs10739076
rs10739076 		A 0.700 GeneticVariation GWASCAT Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria. 30566500

2018
dbSNP: rs11031005
rs11031005
LOC105376607
T 0.700 GeneticVariation GWASCAT Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria. 30566500

2018
dbSNP: rs11225154
rs11225154
YAP1
A 0.700 GeneticVariation GWASCAT Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria. 30566500

2018
dbSNP: rs13164856
rs13164856
IRF1-AS1
T 0.700 GeneticVariation GWASCAT Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria. 30566500

2018